Clinical trial
Efficacy of Oral Semaglutide in Overweight or Obesity
NCT05442450
Study timeline
Study start (actual)2022-07-10Date precision: day
Registry last updated2022-07-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obesityunresolved
Weight Lossunresolved
Interventions
oral semaglutideDRUG
Sponsors & collaborators
Asian Institute of Gastroenterology, Indialead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05442450 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.